you said ....
In other news, Novartis today announced a collaboration with Lantheus to include Pylarify in their clinical trials for Pluvicto for the selection of patients with prostate cancer. This will no doubt further reduce market share for Illuccix.
... well that's not good hey ? i would have thought CB had built a relationship with them from the last tim ethey did work together ? and have i understood correctly , that Novartis have their Therapeutucs approved by FDA ? TLX is years off that happening ? how can that not have been a massive discussion point over the years ?
.. and i didnt bother following up, but im certain in either september or december , CB said news from China was imminent. but nothing since. and although i could be wrong, from memory, i dont think china Grand took up any allocation at $7.70
must be at the bottom with all this average news ???
you said ....In other news, Novartis today announced a...
-
- There are more pages in this discussion • 175 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.08 |
Change
-0.240(1.24%) |
Mkt cap ! $6.384B | |||
| Open | High | Low | Value | Volume |
| $18.82 | $19.08 | $17.60 | $55.33M | 2.964M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27 | $18.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.08 | 6015 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |